Patients, providers, and health systems continue to grapple with unsustainably high prescription drug prices in the United States.
It doesn’t take an economist to recognize that drug makers rarely compete on price. This is one reason why the U.S. spent over $633 billion on prescription drugs last year. Compared with peer nations, the United States has had the highest per capita prescription drug spending for more than a decade. The broken prescription drug market with high prescription drug prices makes health care unaffordable for millions. But we have some policy options.
Patients deserve access to drugs proven to work at prices we all can afford.
Featured content
